Author

Ella F. Whittle

University College LondonORCID 0000-0001-9988-6056Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 2 Research Focus:benchmarking· 2 Research Focus:database / resource· 2 Research Focus:software / tool· 1 Approach:statistical model· 1

Frequent Co-Authors

Alice E. DavidsoniD· 2 shared Kylie MontgomeryiD· 2 shared Marlen C. LaufferiD· 2 shared Mina RyteniD· 2 shared Nour M. ElkhateebiD· 2 shared Stephan SandersiD· 2 shared Timothy W. YuiD· 2 shared Aastha Gandhi· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Alice E. DavidsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintMar 26, 2026

A scalable and equitable framework for target and patient prioritisation in rare disease antisense therapeutics

Ella F. Whittle, Kylie Montgomery, Carme Camps…·Mina Ryten

The paper presents a framework for prioritizing targets and patients for antisense oligonucleotide therapies in rare diseases, focusing on equitable and systematic decision-making.

1 citation

statistical modelbenchmark study

𝕏 PostBluesky

Genetic & Genomic MedicineThe American Journal of Human GeneticsPeer-reviewedMar 26, 2025

Consensus guidelines for eligibility assessment of pathogenic variants to antisense oligonucleotide treatments

David Cheerie, Margaret M. Meserve, Danique Beijer…·Marlen C. Lauffer

The paper presents consensus guidelines for assessing pathogenic variants' eligibility for antisense oligonucleotide treatments, including classification criteria and considerations for different therapeutic approaches.

31 citationstop 1%

benchmark studydatabase / resource

𝕏 PostBluesky